Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy

Completed · Phase 4

Conditions studied: Drug/Agent Toxicity by Tissue/Organ, Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Chemoprotective drugs, such as amifostine, may protect normal cells from the side effects of chemotherapy. PURPOSE: Phase IV trial to study the effectiveness of amifostine in treating patients with cancer who have neurological changes caused by chemotherapy.

Key facts

Study ID

NCT00003252

Run by

Rush North Shore Medical Center

Starts

1997-12-01

Expected to finish

2004-09-01

Last updated by the study team

2013-03-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Rush North Shore Medical Center — Skokie, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.